by Regulatory Exclusivity: How Non-Patent Protections Delay Generic Drugs
6 Dec, 2025Regulatory exclusivity gives drugmakers exclusive market rights for 5 to 12 years after FDA approval, blocking generics even after patents expire. It's a key driver of drug pricing and innovation incentives.
READ MORE